Skip to main content
Article thumbnail
Location of Repository

Antiallodynic Effect of Herbal Medicine Yokukansan on Peripheral Neuropathy in Rats with Chronic Constriction Injury

By Yasuyuki Suzuki, Hiromasa Mitsuhata, Mitsutoshi Yuzurihara and Yoshio Kase


Yokukansan, one of the traditional Japanese herbal medicines, ameliorated neuropathic pain symptoms in patients. In this study, we investigated the effects of yokukansan on neuropathic pain in chronic constriction injury (CCI) model. Oral administration of yokukansan significantly inhibited mechanical and cold allodynia in the von Frey hair or acetone test, respectively. In comparison, amitriptyline, a tricyclic antidepressant, demonstrated moderate, but not significant, antiallodynic effects in the mechanical and cold tests. Yokukansan significantly inhibited the cerebrospinal fluid dialysate level of glutamate that had increased by the stimulation of brush or acetone. Glutamate transporter inhibitors, DL-threo-beta-hydroxy aspartate and dihydrokainate, decreased the yokukansan-induced antiallodynic actions in CCI rats. Our results suggest that yokukansan was confirmed to have antiallodynic effects in CCI rats, which are related to a blockade of glutamatergic neurotransmission via activation of glutamate transporters in the spinal cord

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2007). A comparison of the glutamate release inhibition and antiallodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain,”
    2. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man,”
    3. (2005). A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients,”
    4. (2009). a w a k a m i ,H .K a n n o ,T .U e k ie ta l . ,“ N e u r o p r o t e c t i v ee f -fects of yokukansan, a traditional japanese medicine, on glutamate-mediated excitotoxicity in cultured cells,”
    5. (2003). Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats,”
    6. (2007). Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats,”
    7. (2005). Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain,”
    8. (1999). Antinociceptivepropertiesoffenfluramine,aserotoninreuptakeinhibitor, in a rat model of neuropathy,”
    9. (1994). Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain,”
    10. (2005). Comparison of five different rat models of peripheral nerve injury,”
    11. (2005). Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies,”JournalofClinicalPsychiatry,vol.66,no.12,pp.1612– 1613,
    12. (2009). Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats,”
    13. (1999). Efficacy of pharmacological treatments of neuropathic pain: an update and effect relatedEvidence-Based Complementary and Alternative Medicine 7 to mechanism of drug action,”
    14. (2009). Efficacy of traditional herbal medicine Yokukansan on patients with neuropathic pain,”
    15. (2010). EFNS guidelines on the pharmacological treatment of neuropathic pain:
    16. (2008). Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats,”
    17. Glycyrrhizin and its metabolite 18β-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiencyinduced dysfunction of glutamate transport in cultured rat cortical astrocytes,”
    18. (2006). H.R.Weng,J.H.Chen,andJ.P.Cata,“Inhibitionofglutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation,”
    19. (2007). H.R.Weng,J.H.Chen,Z.Z.Pan,andH.Nie,“Glialglutamate transporter 1 regulates the spatial and temporal coding of glutamatergic synaptic transmission in spinal lamina II neurons,”
    20. (1996). Involvement of increased excitatoryaminoacidsandintracellularCa2+ concentrationinthe spinal dorsal horn in an animal model of neuropathic pain,”
    21. (1998). M.Sasaki,C.Tohda,andY.Kuraishi,“Region-specificincrease in glutamate release from dorsal horn of rats with adjuvant inflammation,”
    22. (1998). Pain assessment and evaluation of patients who have neuropathic pain,”
    23. (1998). Painful neuropathies,”
    24. (2004). Pharmacological characterization of the chronic constriction injury model of neuropathic pain,”
    25. (2010). Pharmacological management of neuropathic pain in non-specialist settings:
    26. (1992). S.R.Skilling,D.H.Harkness,andA.A.Larson,“Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord,”
    27. (1997). Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism,” Pain,v o l .7 3 ,n o .1 ,p p .
    28. (2005). Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord,”
    29. (1992). Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists,”
    30. (2011). Yokukansan enhances pentobarbital-induced sleep in socially isolated mice: possible involvement of GABAA—benzodiazepine receptor complex,”

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.